ATE380243T1 - Epstein-barr-virus verwandte peptide und nukleinsäuresegmente - Google Patents

Epstein-barr-virus verwandte peptide und nukleinsäuresegmente

Info

Publication number
ATE380243T1
ATE380243T1 AT02075193T AT02075193T ATE380243T1 AT E380243 T1 ATE380243 T1 AT E380243T1 AT 02075193 T AT02075193 T AT 02075193T AT 02075193 T AT02075193 T AT 02075193T AT E380243 T1 ATE380243 T1 AT E380243T1
Authority
AT
Austria
Prior art keywords
nucleic acid
ebv
epstein
peptides
antibodies
Prior art date
Application number
AT02075193T
Other languages
English (en)
Inventor
J M Middeldorp
Original Assignee
Biomerieux Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Bv filed Critical Biomerieux Bv
Application granted granted Critical
Publication of ATE380243T1 publication Critical patent/ATE380243T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT02075193T 1992-03-13 1993-03-10 Epstein-barr-virus verwandte peptide und nukleinsäuresegmente ATE380243T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200721 1992-03-13

Publications (1)

Publication Number Publication Date
ATE380243T1 true ATE380243T1 (de) 2007-12-15

Family

ID=8210477

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02075193T ATE380243T1 (de) 1992-03-13 1993-03-10 Epstein-barr-virus verwandte peptide und nukleinsäuresegmente
AT93200691T ATE222291T1 (de) 1992-03-13 1993-03-10 Epstein-barr-virus verwandte peptide und nukleinsäuresegmenten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT93200691T ATE222291T1 (de) 1992-03-13 1993-03-10 Epstein-barr-virus verwandte peptide und nukleinsäuresegmenten

Country Status (13)

Country Link
US (1) US5424398A (de)
EP (2) EP0574048B1 (de)
JP (3) JP4135996B2 (de)
KR (1) KR100291247B1 (de)
AT (2) ATE380243T1 (de)
AU (1) AU666920B2 (de)
CA (1) CA2092680C (de)
DE (2) DE69332197T2 (de)
DK (2) DK0574048T3 (de)
ES (2) ES2184735T3 (de)
FI (1) FI114802B (de)
PT (1) PT574048E (de)
ZA (1) ZA931797B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330966T2 (de) * 1993-07-23 2002-06-06 Wolf, Hans DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests
EP0649904B1 (de) * 1993-09-14 2003-01-22 bioMérieux BV Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
US5834747A (en) * 1994-11-04 1998-11-10 Pixel Instruments Universal credit card apparatus and method
DE19526384C2 (de) * 1995-07-19 1997-07-10 Biotest Ag Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, sowie diese enthaltende Testkits zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
US5813500A (en) * 1996-03-25 1998-09-29 Tenneco Automotive Inc. Anti-swish mechanism for a damper
FR2765688B1 (fr) 1997-07-04 1999-09-10 Pasteur Institut Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
US7105496B2 (en) 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US6797691B1 (en) 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
KR100631766B1 (ko) * 1997-10-07 2006-10-09 오노 야꾸힝 고교 가부시키가이샤 폴리펩티드, 그 폴리펩티드를 암호화하는 ｃＤＮＡ 및그들의 용도
CA2321654C (en) 1998-03-04 2011-02-15 Marcel Bartolina Hendrikus Johannes Vervoort Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid
US20030064917A1 (en) * 1998-07-23 2003-04-03 Crawford Susan E. Methods and compositions for inhibiting angiogenesis
US6159950A (en) * 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
AU2001239884B2 (en) * 2000-02-25 2006-08-10 Vegenics Limited Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins and screening methods for modulators
EP1435776A4 (de) * 2001-09-24 2006-01-25 Univ Pittsburgh Impfstoff gegen krebs sowie diagnoseverfahren und -reagenzien
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US20050063947A1 (en) * 2002-03-27 2005-03-24 Patrick Hwu Method for treating cancer in humans
US7507568B2 (en) * 2002-09-25 2009-03-24 The Proctor & Gamble Company Three dimensional coordinates of HPTPbeta
US7226755B1 (en) * 2002-09-25 2007-06-05 The Procter & Gamble Company HPTPbeta as a target in treatment of angiogenesis mediated disorders
US6886670B2 (en) * 2003-09-29 2005-05-03 Tenneco Automotive Operating Company Inc. Extra support land for valve disc
DE10307517A1 (de) * 2003-02-21 2004-09-02 Mikrogen Molekularbiologische Entwicklungs-Gmbh Von Kapsidantigenen des Epstein-Barr-Virus abgeleitete Peptide und ihre Verwendung
US6899207B2 (en) 2003-09-29 2005-05-31 Tenneco Automotive Operating Company Inc. Extra support area for valve disc
AU2005255019B2 (en) * 2004-06-12 2011-05-19 Oregon Health And Science University Compositions and methods for diagnosis and treatment of orthopoxviruses
US7278987B2 (en) * 2004-07-09 2007-10-09 Anthony Solazzo Ergonomic urological catheterization/irrigation tray
WO2007044033A2 (en) 2004-12-07 2007-04-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
US8088729B2 (en) 2005-12-01 2012-01-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Anti-viral griffithsin compounds, compositions and methods of use
CN101374860A (zh) 2005-12-23 2009-02-25 技术转让合伙人公司 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
US7868228B2 (en) 2006-01-31 2011-01-11 Monsanto Technology Llc Phosphopantetheinyl transferases from bacteria
KR101482483B1 (ko) 2006-04-07 2015-01-15 에르피오 세러퓨틱스 인코포레이티드 인간 단백질 타이로신 포스파타아제 베타(ｈｐｔｐ베타)에 결합하는 항체 및 그의 용도
US8846685B2 (en) 2006-06-27 2014-09-30 Aerpio Therapeutics Inc. Human protein tyrosine phosphatase inhibitors and methods of use
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
US7795444B2 (en) 2006-06-27 2010-09-14 Warner Chilcott Company Human protein tyrosine phosphatase inhibitors and methods of use
US7589212B2 (en) * 2006-06-27 2009-09-15 Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
AU2009262199B2 (en) 2008-06-27 2012-08-09 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
US8748170B2 (en) 2008-07-25 2014-06-10 University of Pittsburgh—of the Commonwealth System of Higher Education Polypeptides derived from cyclin B1 and uses thereof
WO2010045324A1 (en) 2008-10-14 2010-04-22 Monsanto Technology Llc Utilization of fatty acid desaturases from hemiselmis spp.
US9096555B2 (en) 2009-01-12 2015-08-04 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome
ES2726946T3 (es) 2009-07-06 2019-10-10 Aerpio Therapeutics Inc Derivados de benzosulfonamida, composiciones de los mismos y su uso en la prevención de la metástasis de las células cancerosas
US8883832B2 (en) 2009-07-06 2014-11-11 Aerpio Therapeutics Inc. Compounds, compositions, and methods for preventing metastasis of cancer cells
WO2012009705A1 (en) 2010-07-15 2012-01-19 Zyngenia, Inc. Ang-2 binding complexes and uses thereof
CA2827170A1 (en) 2011-02-11 2012-08-16 David M. Hilbert Monovalent and multivalent multispecific complexes and uses thereof
EP2714738B1 (de) 2011-05-24 2018-10-10 Zyngenia, Inc. Multivalente und monovalente multispezifische komplexe und ihre verwendungen
WO2013025479A1 (en) 2011-08-16 2013-02-21 Emory University Jaml specific binding agents, antibodies, and uses related thereto
CA2850830A1 (en) 2011-10-13 2013-04-18 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome and cancer
MX2015013163A (es) 2013-03-15 2016-04-04 Zyngenia Inc Complejos multiespecificos multivalente y monovalentes y sus usos.
EP2813849A1 (de) * 2013-06-10 2014-12-17 Charité-Universitätsmedizin Berlin (Charité) EBV-spezifische Immunsignatur als Diagnosemarker bei chronischem Erschöpfungssyndrom (CFS)
AU2015204680B2 (en) 2014-01-09 2019-07-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-viral cnidarins
ES2781085T3 (es) 2015-02-10 2020-08-28 Us Health Mutantes de griffithsina
EP3256144B1 (de) 2015-02-13 2021-03-24 The Board of Trustees of the University of Illionis Peptidhemmung von ccr3-vermittelten krankheiten oder zuständen
JP2018522547A (ja) 2015-06-15 2018-08-16 モナッシュ ユニバーシティ Ｉｌ−３７バリアント
US10703786B2 (en) 2015-10-30 2020-07-07 The University Of Melbourne Methods and compositions for improving glucose metabolism
CN108490177B (zh) * 2018-02-08 2020-12-29 深圳市新产业生物医学工程股份有限公司 鼻咽癌抗体检测试剂、其制备方法及鼻咽癌检测试剂盒
US20220265759A1 (en) 2019-07-29 2022-08-25 The Board Of Trustees Of The University Of Illiois Composition and method for promoting wound healing
JP7751581B2 (ja) 2019-12-20 2025-10-08 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Ｉｌ－３７融合タンパク質及びその使用
EP4247840A1 (de) 2020-11-18 2023-09-27 The United States of America, as represented by the Secretary, Department of Health and Human Services Tyrosyl-lock-peptide
JP2025511221A (ja) 2022-04-01 2025-04-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ Ｎｏｔｃｈ１およびｎｏｔｃｈ４デコイとその使用方法
CN115684584B (zh) * 2022-11-01 2026-04-21 郑州安图生物工程股份有限公司 Eb病毒磁微粒化学发光检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141783B2 (de) * 1983-11-07 1993-06-16 The Wistar Institute Durch antiidiotype Antikörper induzierte immune Antwort zu Tumoren und Viren
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
IE873041L (en) * 1987-11-11 1989-05-11 Ailbe Brennan Viral antigens, diagnostic assay therefor and vaccines¹containing them
WO1991002091A1 (en) * 1989-08-10 1991-02-21 Northwestern University Method of identifying herpesviruses and oligonucleotides for use therein
US5374517A (en) * 1989-11-24 1994-12-20 Council Of The Queensland Institute Of Medical Research IM peptides
DE69013011T2 (de) * 1989-12-20 1995-02-23 Schering Corp., Kenilworth, N.J. Bcrf1-proteine als inhibitoren von interferon-g(g).
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット

Also Published As

Publication number Publication date
ES2298325T3 (es) 2008-05-16
PT574048E (pt) 2002-12-31
FI114802B (fi) 2004-12-31
EP0574048B1 (de) 2002-08-14
EP1225226B1 (de) 2007-12-05
US5424398A (en) 1995-06-13
ATE222291T1 (de) 2002-08-15
DK0574048T3 (da) 2002-12-16
EP1225226A1 (de) 2002-07-24
ZA931797B (en) 1993-09-30
JP2008261851A (ja) 2008-10-30
FI931109L (fi) 1993-09-14
KR100291247B1 (ko) 2001-06-01
JP4135996B2 (ja) 2008-08-20
DE69334191D1 (de) 2008-01-17
CA2092680A1 (en) 1993-09-14
JPH0690787A (ja) 1994-04-05
KR930019829A (ko) 1993-10-19
JP2004261183A (ja) 2004-09-24
ES2184735T3 (es) 2003-04-16
DE69334191T2 (de) 2008-11-27
JP4106041B2 (ja) 2008-06-25
FI931109A0 (fi) 1993-03-12
EP0574048A3 (de) 1994-03-02
DK1225226T3 (da) 2008-04-14
AU3515293A (en) 1993-09-16
CA2092680C (en) 2006-08-08
DE69332197T2 (de) 2003-04-17
AU666920B2 (en) 1996-02-29
EP0574048A2 (de) 1993-12-15
DE69332197D1 (de) 2002-09-19
JP4365440B2 (ja) 2009-11-18

Similar Documents

Publication Publication Date Title
DE69334191D1 (de) Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente
EP0484787A3 (en) Hcv-specific peptides, process for obtaining them and their use
CY2053B1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
KR950704489A (ko) 인터페론 타우 조성물 및 사용방법(interferon tau compositions and methods of use)
CA2273196A1 (en) Isolated mammalian monocyte cell genes; related reagents
JPS6420095A (en) Polypeptide having anti-blood coagulating action
MY135991A (en) A vaccine-induced hepatits b viral strain and uses thereof
DK35891D0 (da) Praktisk taget rent, antigenisk peptid eller protein med en epitop af haemophilus influenzae, dets fremstilling og anvendelse
EP0733643A4 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä-b zellen und sein gen
DK326289D0 (da) Fremgangsmaade til fremstilling af et protein ud fra gaersvampe under anvendelse af et inducerbart system, samt vektorer og transformerede stammer til brug ved fremgangsmaaden
Roeckel et al. Biochemical characterization of two Epstein-Barr virus early antigen-associated phosphopolypeptides
RU94045154A (ru) Полипептиды, их фрагменты и варианты, препарат, днк вектор, клетка, способ продукции полипептида, вакцины, способы защиты, антитело и его фрагмент, их применение, применение днк, способ идентификации антигена
EP0754755A3 (de) Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
Middeldorp et al. Peptides and nucleic acid sequences related to the Epstein Barr virus
NO910479L (no) Syntetiske polypeptider og antistoffer relatert til epstein-barr-virus-kjerneantigen.
Greenham et al. Application of potassium thiocyanate as a destaining agent for confirming the specificity of viral immunofluorescence
KR950704353A (ko) 씨(c)형 간염 비루스(hcv) 비-구조-3 펩티드, 그에 대한 항체 및 에이취씨브이(hcv)의 검출 방법(hepatitis c virus(hcv) non-structurac-3 peptides, antibodies thereto and methods for the detection of hcv)
INAGAKI et al. Detection of SS-A/Ro and SS-B/La Autoantibodies Using Immunoblotting Procedure and Characterization of the Antigens from 293 Cells and KB Cells
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv
RU98119633A (ru) Способ получения полипептида, обладающего антигенной активностью вируса гепатита е. набор для определения антител к возбудителю гепатита е - вирусу гепатита е
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties